Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cnossen

Showing results (391-400 of 442) with videos related to

Pageof 45
Sort By:
Blood Advances|November 7, 2023
One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label studyMyrthe J van Dijk, Minke A E Rab, Brigitte A van Oirschot, et al.
American Journal of Hematology|February 21, 2019
Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patientsMinke A E Rab, Brigitte A van Oirschot, Jennifer Bos, et al.
Research and Practice in Thrombosis and Haemostasis|May 1, 2024
Predictive performance of pharmacokinetic-guided prophylactic dosing of factor concentrates in hemophilia A and BTine M H J Goedhart, Laura H Bukkems, Anne-Fleur Zwagemaker, et al.
Journal of Medicinal Chemistry|March 19, 2025
Discovery of AIC263282, a Hepatitis B Virus Capsid Assembly Modulator Ready for Candidate ProfilingBernhard Lesch, Alexander Birkmann, Susanne Bonsmann, et al.
Research and Practice in Thrombosis and Haemostasis|May 24, 2021
Patient-relevant health outcomes for hemophilia care: Development of an international standard outcomes setErna C van Balen, Brian O'Mahony, Marjon H Cnossen, et al.
The British Journal of Surgery|May 27, 2023
Locally recurrent rectal cancer: Oncological outcomes for patients with a pathological complete response after neoadjuvant therapyStefi Nordkamp, Floor Piqeur, Kim van den Berg, et al.
Thrombosis and Haemostasis|June 2, 2020
von Willebrand Factor and Factor VIII Clearance in Perioperative Hemophilia A PatientsIris van Moort, Laura H Bukkems, Jessica M Heijdra, et al.
Research and Practice in Thrombosis and Haemostasis|September 27, 2023
Psychometrics of the patient-reported outcomes measurement information system measures in hemophilia: the applicability of the pediatric item banksLorynn Teela, Michiel A J Luijten, Isolde A R Kuijlaars, et al.
BMJ Open|April 25, 2019
Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID studyLisette M Schütte, Marjon H Cnossen, Reinier M van Hest, et al.
Radiation Oncology (London, England)|December 23, 2025
Neoadjuvant chemo-reirradiation followed by resection and intraoperative electron beam radiotherapy: outcomes of multimodality treatment for locally recurrent rectal cancerF E C Vande Kerckhove, F Piqeur, E Banken, et al.
Pageof 45

Showing results (391-400 of 442) with videos related to

Sort By:
Pageof 45
Blood Advances|November 7, 2023
One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label studyMyrthe J van Dijk, Minke A E Rab, Brigitte A van Oirschot, et al.
American Journal of Hematology|February 21, 2019
Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patientsMinke A E Rab, Brigitte A van Oirschot, Jennifer Bos, et al.
Research and Practice in Thrombosis and Haemostasis|May 1, 2024
Predictive performance of pharmacokinetic-guided prophylactic dosing of factor concentrates in hemophilia A and BTine M H J Goedhart, Laura H Bukkems, Anne-Fleur Zwagemaker, et al.
Journal of Medicinal Chemistry|March 19, 2025
Discovery of AIC263282, a Hepatitis B Virus Capsid Assembly Modulator Ready for Candidate ProfilingBernhard Lesch, Alexander Birkmann, Susanne Bonsmann, et al.
Research and Practice in Thrombosis and Haemostasis|May 24, 2021
Patient-relevant health outcomes for hemophilia care: Development of an international standard outcomes setErna C van Balen, Brian O'Mahony, Marjon H Cnossen, et al.
The British Journal of Surgery|May 27, 2023
Locally recurrent rectal cancer: Oncological outcomes for patients with a pathological complete response after neoadjuvant therapyStefi Nordkamp, Floor Piqeur, Kim van den Berg, et al.
Thrombosis and Haemostasis|June 2, 2020
von Willebrand Factor and Factor VIII Clearance in Perioperative Hemophilia A PatientsIris van Moort, Laura H Bukkems, Jessica M Heijdra, et al.
Research and Practice in Thrombosis and Haemostasis|September 27, 2023
Psychometrics of the patient-reported outcomes measurement information system measures in hemophilia: the applicability of the pediatric item banksLorynn Teela, Michiel A J Luijten, Isolde A R Kuijlaars, et al.
BMJ Open|April 25, 2019
Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID studyLisette M Schütte, Marjon H Cnossen, Reinier M van Hest, et al.
Radiation Oncology (London, England)|December 23, 2025
Neoadjuvant chemo-reirradiation followed by resection and intraoperative electron beam radiotherapy: outcomes of multimodality treatment for locally recurrent rectal cancerF E C Vande Kerckhove, F Piqeur, E Banken, et al.
Pageof 45